3933 fundamentals

The United Laboratories International Holdings Ltd. is an investment company, which engages in manufacturing and selling medicine products. It operates through the following segments: Intermediate Products, Bulk Medicine, and Finished Products. The Intermediate Products segment represents sales of 6-APA products and penicillin G potassium products. The Bulk Medicine segment covers the sales of amoxicillin products. The Finished Products segment sells insulin series products, antibiotics products, nervous system drugs, ophthalmic products, and veterinary drugs. The company was founded in 1990 and is headquartered in Hong Kong.